PL3157510T3 - Kompozycje przeciwdrobnoustrojowe z środkami musującymi - Google Patents

Kompozycje przeciwdrobnoustrojowe z środkami musującymi

Info

Publication number
PL3157510T3
PL3157510T3 PL15810507T PL15810507T PL3157510T3 PL 3157510 T3 PL3157510 T3 PL 3157510T3 PL 15810507 T PL15810507 T PL 15810507T PL 15810507 T PL15810507 T PL 15810507T PL 3157510 T3 PL3157510 T3 PL 3157510T3
Authority
PL
Poland
Prior art keywords
antimicrobial compositions
effervescent agents
effervescent
agents
antimicrobial
Prior art date
Application number
PL15810507T
Other languages
English (en)
Inventor
Danping Li
Original Assignee
Melinta Subsidiary Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54868661&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3157510(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Melinta Subsidiary Corp. filed Critical Melinta Subsidiary Corp.
Publication of PL3157510T3 publication Critical patent/PL3157510T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL15810507T 2014-06-20 2015-06-19 Kompozycje przeciwdrobnoustrojowe z środkami musującymi PL3157510T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462014786P 2014-06-20 2014-06-20
PCT/US2015/036605 WO2015196027A1 (en) 2014-06-20 2015-06-19 Antimicrobial compositions with effervescent agents
EP15810507.2A EP3157510B1 (en) 2014-06-20 2015-06-19 Antimicrobial compositions with effervescent agents

Publications (1)

Publication Number Publication Date
PL3157510T3 true PL3157510T3 (pl) 2019-12-31

Family

ID=54868661

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15810507T PL3157510T3 (pl) 2014-06-20 2015-06-19 Kompozycje przeciwdrobnoustrojowe z środkami musującymi
PL19165084T PL3581180T3 (pl) 2014-06-20 2015-06-19 Kompozycje przeciwdrobnoustrojowe z środkami musującymi

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL19165084T PL3581180T3 (pl) 2014-06-20 2015-06-19 Kompozycje przeciwdrobnoustrojowe z środkami musującymi

Country Status (31)

Country Link
US (2) US20150366857A1 (pl)
EP (3) EP3919057A1 (pl)
JP (2) JP6995479B2 (pl)
CN (2) CN114831955B (pl)
AR (1) AR100920A1 (pl)
AU (3) AU2015276954B2 (pl)
BR (1) BR112016029761B1 (pl)
CA (1) CA2952950C (pl)
CL (2) CL2016003273A1 (pl)
CR (2) CR20160592A (pl)
CY (2) CY1121995T1 (pl)
DK (2) DK3581180T3 (pl)
EA (1) EA034152B1 (pl)
EC (1) ECSP16095540A (pl)
ES (2) ES2732865T3 (pl)
HR (2) HRP20211685T1 (pl)
HU (2) HUE044764T2 (pl)
IL (1) IL249622A0 (pl)
LT (2) LT3157510T (pl)
MX (2) MX368940B (pl)
PE (2) PE20170304A1 (pl)
PH (1) PH12016502548A1 (pl)
PL (2) PL3157510T3 (pl)
PT (2) PT3157510T (pl)
RS (2) RS59064B1 (pl)
SI (2) SI3581180T1 (pl)
SV (1) SV2016005349A (pl)
TR (1) TR201909417T4 (pl)
TW (2) TWI705814B (pl)
UY (1) UY36184A (pl)
WO (1) WO2015196027A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022240897A1 (en) * 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194617A (en) * 1988-12-17 1993-03-16 Meiji Seika Kaisha, Ltd. 2,3-disubstituted-4-hydroxyquinoline derivatives
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
PT992501E (pt) 1995-09-22 2003-01-31 Wakunaga Pharma Co Ltd Derivados de acido piridonacarboxilico como agentes antibacterianos
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
PL346798A1 (en) 1998-09-14 2002-02-25 Ranbaxy Lab Ltd Orally administered controlled drug delivery system providing temporal and spatial control
US6187317B1 (en) * 1999-07-14 2001-02-13 Judith Taylor Natural anti-diarrheal composition and method
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
WO2003101431A1 (en) * 2002-06-04 2003-12-11 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
EP1789392A2 (en) 2004-07-30 2007-05-30 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
EP3957632A1 (en) 2004-10-08 2022-02-23 AbbVie Inc. Meglumine salt and crystalline forms thereof of a drug (delafloxacin)
KR20070104884A (ko) * 2004-11-24 2007-10-29 메드포인트 헬쓰케어 인크. 아젤라스틴을 포함하는 조성물 및 이의 사용 방법
PT1868581E (pt) 2005-04-11 2012-06-22 Abbott Lab Composições farmacêuticas que possuem perfis de dissolução melhorados para fármacos pouco solúveis
ATE396710T1 (de) 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
US7611739B2 (en) 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
WO2008021256A2 (en) * 2006-08-11 2008-02-21 Aqua Resources Corporation Nanoplatelet metal hydroxides and methods of preparing same
CN1943561A (zh) * 2006-08-23 2007-04-11 北京阜康仁生物制药科技有限公司 普卢利沙星口腔崩解片及其制备方法
US9205094B2 (en) 2006-12-22 2015-12-08 Ironwood Pharmaceuticals, Inc. Compositions comprising bile acid sequestrants for treating esophageal disorders
CA2687192C (en) * 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
EP2373166A4 (en) * 2008-11-15 2014-11-05 Rib X Pharmaceuticals Inc ANTIMICROBIAL COMPOSITIONS
WO2010096551A2 (en) * 2009-02-18 2010-08-26 Rib-X Pharmaceuticals, Inc. Antimicrobial compositions
GB201020076D0 (en) * 2010-11-26 2011-01-12 Liverpool School Tropical Medicine Antimalarial compounds
CA2824197C (en) * 2011-01-10 2020-02-25 Michael Martin Processes for preparing isoquinolinones and solid forms of isoquinolinones
BR112013017985B1 (pt) * 2011-01-14 2021-06-29 Spero Therapeutics Inc. Formas sólidas de inibidor de girase (r)-1-etil-3-[6-flúor-5-[2-(1-hidróxi-1-metil-etil)pirimidin- 5-il]-7-(tetra-hidrofuran-2-il)-1h-benzimidazol-2-il]ureia, seu sal de ácido clorídrico, método de preparação das mesmas e composição farmacêutica que os compreende
JP2013034468A (ja) * 2011-08-10 2013-02-21 Nisshin Sugar Mfg Co Ltd 発泡成型甘味料
EP2790678A4 (en) * 2011-12-16 2015-09-30 Celanese Eva Performance Polymers Inc CONTROLLED RELEASE EXCIPIENTS COMPRISING ETHYLENE COPOLYMERS, ETHYLCELLULOSES AND / OR THERMOPLASTIC POLYURETHANES
CN102697751A (zh) * 2012-05-30 2012-10-03 河南牧翔动物药业有限公司 一种畜禽专用恩诺沙星泡腾分散片及其制备方法

Also Published As

Publication number Publication date
HUE044764T2 (hu) 2019-11-28
NZ727638A (en) 2023-08-25
AU2020256457A1 (en) 2020-11-12
BR112016029761A2 (pt) 2017-08-22
CN114831955A (zh) 2022-08-02
IL249622A0 (en) 2017-02-28
SI3581180T1 (sl) 2021-12-31
PE20210927A1 (es) 2021-05-19
SI3157510T1 (sl) 2019-09-30
SV2016005349A (es) 2017-08-31
UY36184A (es) 2016-01-29
HUE056298T2 (hu) 2022-02-28
LT3157510T (lt) 2019-09-25
MX2016017350A (es) 2017-04-06
CN114831955B (zh) 2024-03-12
AU2021286284B2 (en) 2024-02-29
JP6995479B2 (ja) 2022-01-14
PH12016502548A1 (en) 2017-04-10
EA201692532A1 (ru) 2017-05-31
AU2015276954A1 (en) 2017-01-12
LT3581180T (lt) 2021-12-27
TW202005650A (zh) 2020-02-01
MX2019012608A (es) 2019-12-02
WO2015196027A1 (en) 2015-12-23
CN106572982B9 (zh) 2022-07-08
JP2020183415A (ja) 2020-11-12
EP3919057A1 (en) 2021-12-08
MX368940B (es) 2019-10-21
CR20200565A (es) 2021-01-14
PT3581180T (pt) 2021-11-09
ES2897576T3 (es) 2022-03-01
CL2016003273A1 (es) 2017-08-04
AR100920A1 (es) 2016-11-09
US20150366857A1 (en) 2015-12-24
TW201625249A (zh) 2016-07-16
AU2021286284A1 (en) 2022-01-06
HRP20191133T1 (hr) 2019-09-20
DK3581180T3 (da) 2021-11-08
EA034152B1 (ru) 2020-01-09
CL2020003153A1 (es) 2021-06-25
ECSP16095540A (es) 2017-03-31
TWI705814B (zh) 2020-10-01
EP3157510B1 (en) 2019-03-27
PL3581180T3 (pl) 2022-02-07
CY1125395T1 (el) 2023-03-24
BR112016029761A8 (pt) 2021-06-29
RS59064B1 (sr) 2019-08-30
EP3581180B1 (en) 2021-08-04
CN106572982A (zh) 2017-04-19
JP2017518349A (ja) 2017-07-06
DK3157510T3 (da) 2019-07-01
PT3157510T (pt) 2019-06-21
TR201909417T4 (tr) 2019-07-22
CR20160592A (es) 2017-02-21
JP7149991B2 (ja) 2022-10-07
AU2020256457B2 (en) 2021-09-30
EP3157510A1 (en) 2017-04-26
EP3157510A4 (en) 2018-02-21
ES2732865T3 (es) 2019-11-26
CN106572982B (zh) 2022-06-03
AU2015276954B2 (en) 2020-07-23
CA2952950C (en) 2023-11-14
RS62538B1 (sr) 2021-12-31
US20200237744A1 (en) 2020-07-30
HRP20211685T1 (hr) 2022-02-04
PE20170304A1 (es) 2017-04-19
EP3581180A1 (en) 2019-12-18
CY1121995T1 (el) 2020-10-14
TWI732337B (zh) 2021-07-01
CA2952950A1 (en) 2015-12-23
BR112016029761B1 (pt) 2023-03-07

Similar Documents

Publication Publication Date Title
GB2573068B (en) Antimicrobial Compositions
GB2535666B (en) Antimicrobial compositions
IL253087A0 (en) Antimicrobial preparation
ZA201607145B (en) Antimicrobial sanitizer compositions and their use
SI3226858T1 (sl) Protimikrobna sredstva na osnovi imidazola
PL3253232T3 (pl) Kompozycje przeciwdrobnoustrojowe
GB201411802D0 (en) Effervescent compositions
IL284723A (en) Antimicrobial preparation
DK3174396T3 (da) Synergistisk antimikrobiel sammensætning
IL249622A0 (en) Antimicrobial preparations with effervescent substances
ZA201901171B (en) Antimicrobial composition
GB201621050D0 (en) Antimicrobial compositions
GB201616985D0 (en) Antimicrobial compositions
GB201611468D0 (en) Antimicrobial composition
GB2552572B (en) Antimicrobial compositions
GB201514490D0 (en) Antimicrobial composition
GB201511254D0 (en) Effervescent compositions
GB201411470D0 (en) Effervescent compositions
HUE038776T2 (hu) Szinergikus felületaktív anyag összetétel
HUE045514T2 (hu) Kézfertõtlenítõ összetétel